Neil Garry Arthur Insider Trades

Insider Trading History

Track insider trading activity for Neil Garry Arthur. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Executive Officer
Holding Value $2.59M 190,314 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.66M 100,200 shares
$16.60
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Executive Officer
Holding Value $1.23M 90,114 shares
Last Trade
Mar 28, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$304k 21,892 shares
$13.89
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Executive Officer
Holding Value $1.52M 112,006 shares
Last Trade
Mar 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$901k 64,866 shares
$13.89
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Executive Officer
Holding Value $883k 64,867 shares
Last Trade
Mar 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$901k 64,866 shares
$13.89
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Executive Officer
Holding Value $3.89M 286,000 shares
Last Trade
Feb 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.05M 286,000 shares
$17.64
$13.61
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $494k 16,500 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$322k 16,500 shares
$19.53
$29.93
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Executive Officer
Holding Value $1.77M 129,733 shares
Last Trade
Mar 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$549k 64,867 shares
$8.46
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
CEO And Chairman Of The Board
Holding Value $5.59M 411,000 shares
Last Trade
Jan 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.3M 411,000 shares
$8.04
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
CEO And Chairman Of The Board
Holding Value $6.81M 500,400 shares
Last Trade
Aug 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.94M 500,400 shares
$9.88
$13.61
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $494k 16,500 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$601k 16,500 shares
$36.43
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $338k 11,300 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$417k 11,300 shares
$36.87
$29.93
Avalo Therapeutics
Avalo Therapeutics AVTX
CEO And Chairman Of The Board
Holding Value $180k 13,220 shares
Last Trade
Jun 09, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.86M 4,000 shares
$964.80
$13.61
JATT Acquisition
JATT Acquisition JATT
Director
Holding Value $62.4k 7,652 shares
Last Trade
May 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.6k 7,652 shares
$5.31
$8.16
Zura Bio Ltd - Warrants (20/03/2028)
Zura Bio Ltd - Warrants (20/03/2028) ZURAW
Director
Holding Value $3.75k 7,652 shares
Last Trade
May 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.32k 7,652 shares
$0.30
$0.49
Zura Bio
Zura Bio ZURA
Director
Holding Value $28.1k 7,652 shares
Last Trade
May 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.6k 7,652 shares
$5.31
$3.67
Avalo Therapeutics
Avalo Therapeutics AVTX
CEO And Chairman Of The Board
Holding Value $1.36M 100,000 shares
Last Trade
May 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66M 100,000 shares
$660.00
$13.61
JATT Acquisition
JATT Acquisition JATT
Director
Holding Value $0 0 shares
Last Trade
Mar 20, 2023 Sale
$104k 12,754 shares
$8.16
$8.16
Avalo Therapeutics
Avalo Therapeutics AVTX
CEO And Chairman Of The Board
Holding Value $1.36M 100,000 shares
Last Trade
Feb 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.5M 100,000 shares
$715.20
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
CEO And Chairman Of The Board
Holding Value $125k 9,220 shares
Last Trade
Dec 09, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.6M 2,083 shares
$1,248.00
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
CEO And Chairman Of The Board
Holding Value $1.02M 75,000 shares
Last Trade
Oct 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.5M 75,000 shares
$952.80
$13.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up